Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02267603
Title Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Palo Alto Palo Alto California 94304 United States Details
UCSF Medical Center-Mount Zion San Francisco California 94115 United States Details
Yale University New Haven Connecticut 06520 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Louisiana State University Health Science Center New Orleans Louisiana 70112 United States Details
University Medical Center New Orleans New Orleans Louisiana 70112 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Mount Sinai Hospital New York New York 10029 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field